Offer - Urjas Oil for just ₹ 1 X
Clomilent 50 Tablet is a prescription drug, available for use as Tablet. Obsessive Compulsive Disorder are some of its major therapeutic uses.
The right dosage of Clomilent 50 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Clomilent 50 Tablet have been listed ahead. Normally, these side effects of Clomilent 50 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Clomilent 50 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Clomilent 50 Tablet's effects on the liver, heart and kidney are discussed below in the Clomilent 50 Tablet related warnings section.
Clomilent 50 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency are examples of such conditions. Some other conditions that can be affected by Clomilent 50 Tablet are listed in the contraindications section below.
Additionally, Clomilent 50 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Clomilent 50 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Clomilent 50 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Clomilent 50 Tablet safe for pregnant women?
Clomilent may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Clomilent again without your doctor's advice.
Is the use of Clomilent 50 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Clomilent. So it is adviced to consult the doctor before using it.
What is the effect of Clomilent 50 Tablet on the Kidneys?
There are no side effects of Clomilent on the kidneys.
What is the effect of Clomilent 50 Tablet on the Liver?
Clomilent may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Clomilent 50 Tablet on the Heart?
Clomilent is rarely harmful for the heart.
Clomilent 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Clomilent 50 Tablet unless your doctor advises you to do so -
Is this Clomilent 50 Tablet habit forming or addictive?
Clomilent 50 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Clomilent 50 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Clomilent 50 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Clomilent 50 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Clomilent 50 Tablet
It is safe to take Clomilent 50 Tablet with food.
Interaction between Alcohol and Clomilent 50 Tablet
Taking alcohol with Clomilent 50 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464